Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma.
暂无分享,去创建一个
M. Fiorentino | A. Ardizzoni | F. Massari | R. Schiavina* | E. Brunocilla | V. Mollica | V. Di Nunno | E. Nobili | R. Schiavina
[1] T. Powles,et al. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell Carcinoma , 2019, The New England journal of medicine.
[2] R. Motzer,et al. Avelumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell Carcinoma , 2019, The New England journal of medicine.
[3] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[4] C. Porta,et al. Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis? , 2018, Clinical genitourinary cancer.
[5] Bohuslav Melichar,et al. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal‐Cell Carcinoma , 2018, The New England journal of medicine.
[6] S. Signoretti,et al. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model. , 2017, The oncologist.
[7] R. Motzer,et al. Systemic Therapy for Metastatic Renal-Cell Carcinoma. , 2017, The New England journal of medicine.
[8] P. Kuo,et al. Bone Metastasis from Renal Cell Carcinoma , 2016, International journal of molecular sciences.
[9] K. Chuah,et al. Metastatic Renal Cell Carcinoma to the Pancreas: A Review. , 2016, Archives of pathology & laboratory medicine.
[10] A. Ravaud,et al. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. , 2015, The New England journal of medicine.
[11] T. Choueiri,et al. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. , 2013, The Lancet. Oncology.
[12] W. Gregory,et al. Skeletal complications and survival in renal cancer patients with bone metastases. , 2011, Bone.
[13] Wanling Xie,et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] A. Belldegrun,et al. Brain metastasis from renal cell carcinoma , 2008, Cancer.
[15] M. Kattan,et al. Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma , 2008, Cancer.
[16] T. Mekhail,et al. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.